(DBVT) DBV Technologies - Performance 4.8% in 12m
Compare DBVT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-76.20%
#132 in Group
Rel. Strength
58.10%
#3246 in Universe
Total Return 12m
4.80%
#36 in Group
Total Return 5y
-79.10%
#93 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -
(unknown) Percentile in Group
12m Total Return: DBVT (4.8%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-4.65% | 17.9% | 229% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-0.86% | 32.9% | 221% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.23% | 27.5% | 43.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-0.3% | 16.4% | 70.8% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.03% | -0.49% | 38.3% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.85% | 21.5% | 13.9% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
-4.86% | 15.4% | 6.78% | 27 | 25 | 1 | 58.7% | 15% |
| ERF PA Eurofins Scientific SE |
0.82% | -17.5% | 16.4% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: DBVT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DBVT
| Total Return (including Dividends) | DBVT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 98.48% | -8.71% | -7.79% |
| 3 Months | 133.93% | -15.44% | -9.06% |
| 12 Months | 4.80% | -14.04% | 4.64% |
| 5 Years | -79.10% | -2.41% | 117.94% |
| Trend Score (consistency of price movement) | DBVT | XBI | S&P 500 |
| 1 Month | 47.1% | -62.6% | -5.5% |
| 3 Months | 30.5% | -73% | -61.9% |
| 12 Months | -46.2% | -8.4% | 82.8% |
| 5 Years | -87.2% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #3 | 117% | 115% |
| 3 Month | #3 | 177% | 157% |
| 12 Month | #37 | 21.9% | 0.15% |
| 5 Years | #97 | -78.6% | -90.4% |
FAQs
Does DBVT DBV Technologies outperforms the market?
Yes,
over the last 12 months DBVT made 4.80%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.04%.
Over the last 3 months DBVT made 133.93%, while XBI made -15.44%.
Over the last 3 months DBVT made 133.93%, while XBI made -15.44%.
Performance Comparison DBVT vs Indeces and Sectors
DBVT vs. Indices DBVT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 106% | 106% | 136% | 0.16% |
| US NASDAQ 100 | QQQ | 107% | 108% | 137% | 2.24% |
| US Dow Jones Industrial 30 | DIA | 105% | 105% | 134% | -0.45% |
| German DAX 40 | DAX | 105% | 105% | 117% | -12.7% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 104% | 99.3% | 146% | -3.30% |
| Hongkong Hang Seng | HSI | 103% | 97.5% | 140% | -11.7% |
| India NIFTY 50 | INDA | 102% | 91.4% | 141% | 5.05% |
| Brasil Bovespa | EWZ | 101% | 89.4% | 137% | 16.1% |
DBVT vs. Sectors DBVT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 107% | 107% | 128% | -8.20% |
| Consumer Discretionary | XLY | 107% | 108% | 133% | -2.30% |
| Consumer Staples | XLP | 99.5% | 99.8% | 129% | -8.11% |
| Energy | XLE | 108% | 98.9% | 136% | 12.5% |
| Financial | XLF | 106% | 106% | 124% | -11.5% |
| Health Care | XLV | 102% | 102% | 136% | 3.82% |
| Industrial | XLI | 106% | 105% | 137% | 2.66% |
| Materials | XLB | 105% | 103% | 143% | 13.6% |
| Real Estate | XLRE | 102% | 104% | 136% | -5.11% |
| Technology | XLK | 109% | 109% | 143% | 10.0% |
| Utilities | XLU | 99.1% | 98.3% | 133% | -20.1% |
| Aerospace & Defense | XAR | 106% | 102% | 131% | -10.4% |
| Biotech | XBI | 110% | 107% | 150% | 18.8% |
| Homebuilder | XHB | 108% | 105% | 156% | 19.7% |
| Retail | XRT | 107% | 107% | 143% | 16.4% |